Gene · 7874
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A homologous cell membrane-coated peptide-based USP7 degrader enhances degradation efficiency and anti-tumor activity in gastric Cancer. | Bioorg Chem | 2026 | 42284879 | PubTator, text mining | PubMed |
| High-throughput screening identifies a critical role of the SPOP-PABPC1 axis in lung adenocarcinoma progression. | Proc Natl Acad Sci U S A | 2026 | 42268896 | PubTator, text mining | PubMed |
| Emerging roles of USP7 in tumor immune evasion, metabolic reprogramming, and therapeutic resistance. | Front Immunol | 2026 | 42245660 | PubTator, text mining | PubMed |
| DOT1L shapes ncPRC1 target gene repression to maintain germinal center B-cell identity in diffuse large B-cell lymphoma. | Blood | 2026 | 42213647 | PubTator, text mining | PubMed |
| Deubiquitinases in lung cancer: Oncogenic mechanisms, metabolic reprogramming, immune evasion, and therapeutic targeting. | Pathol Res Pract | 2026 | 42208358 | PubTator, text mining | PubMed |
| USP7 inhibition perturbs proteostasis and tumorigenesis in triple-negative breast cancer. | NPJ Breast Cancer | 2026 | 42177192 | PubTator, text mining | PubMed |
| Deubiquitinases at the crossroads of ferroptosis and cancer therapy: mechanisms and therapeutic potential. | Mol Biol Rep | 2026 | 42171907 | PubTator, text mining | PubMed |
| USP21 functions as an oncogenic regulator of the Mdm2-p53 axis in colorectal cancer. | Cell Death Discov | 2026 | 42168156 | PubTator, text mining | PubMed |
| The Host Cell Factor Phosphatase-2A Subunit PR130 Restricts Replication of Herpes Simplex Virus Type-1. | Adv Sci (Weinh) | 2026 | 42138961 | PubTator, text mining | PubMed |
| Targeted degradation of USP7 in solid cancer cells reveals distinct effects of deubiquitinase degraders and inhibitors. | Nat Commun | 2026 | 42129197 | PubTator, text mining | PubMed |
| TRIP12 promotes HIV-1 replication and latency reactivation by stabilizing Tat via USP7-mediated deubiquitination. | J Virol | 2026 | 42126234 | PubTator, text mining | PubMed |
| USP7 at PML Nuclear Bodies: A Protein Interaction Network Perspective. | Int J Mol Sci | 2026 | 42123684 | PubTator, text mining | PubMed |
| All-trans retinoic acid destabilizes ADAR1 protein through retinoylation-mediated USP7 dissociation and improves immunotherapy in pancreatic cancer. | Nat Commun | 2026 | 42115161 | PubTator, text mining | PubMed |
| Deubiquitination of ETV4 by USP7 Promotes NSCLC Tumorigenesis via MAPK7 Activation. | Hum Mutat | 2026 | 42100492 | PubTator, text mining | PubMed |
| Mechanisms of USP7/MAGEL2 Complex Assembly and Its Mutational Disruption in Neurodevelopmental Diseases. | bioRxiv | 2026 | 42094436 | PubTator, text mining | PubMed |
| USP7-stabilized CEBPB promotes HpSCC progression by upregulating IL6 to activate the JAK2/STAT3 signaling. | Mol Cell Biochem | 2026 | 42048037 | PubTator, text mining | PubMed |
| USP7-dependent stabilization of FKBP4 contributes to acquired osimertinib resistance through glycolytic remodeling in NSCLC. | Sci Rep | 2026 | 42031983 | PubTator, text mining | PubMed |
| USP7-mediated deubiquitination of the KEAP1-NRF2-HMOX1 axis enhances radioresistance in non-small cell lung cancer by suppressing ferroptosis. | Oncogene | 2026 | 42026186 | PubTator, text mining | PubMed |
| Overexpression of miR-7641 activates ox-LDL-induced autophagy in macrophages by regulating USP7. | Mol Biol Rep | 2026 | 42018035 | PubTator, text mining | PubMed |
| Epithelial TRIM27 Inhibits Intestinal Inflammation in Ulcerative Colitis by the USP7/TRIM27-IKK Double Negative-Feedback. | Adv Sci (Weinh) | 2026 | 42017384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7874/papers?page=3